Welch G N, Upchurch G R, Farivar R S, Pigazzi A, Vu K, Brecher P, Keaney J F, Loscalzo J
Whitaker Cardiovascular Institute, Boston University School of Medicine, MA 02118, USA.
Proc Assoc Am Physicians. 1998 Jan-Feb;110(1):22-31.
Increased plasma levels of homocysteine are an independent risk factor for atherothrombosis. While the endothelial cytotoxicity of homocysteine has been attributed to oxidative stress associated with the reactivity of the thiol group, the oxidative effect of homocysteine on vascular smooth-muscle cells has not been investigated. Recent evidence suggests that expression of inducible nitric oxide synthase (iNOS), or Nos2 gene product, in vascular smooth-muscle cells may, in part, promote atherosclerosis by increasing local oxidative stress. We therefore hypothesized that homocysteine contributes to atherosclerosis by affecting cytokine-induced production of nitric oxide (NO) by vascular smooth-muscle cells. Confluent rat aortic smooth-muscle cells were exposed to a range of concentrations of homocysteine for 4 hr, then were treated with interferon-gamma, interleukin-1 beta, and lipopolysaccharide to induce iNOS. Media NOx content (nitrite plus S-nitrosothiol) was measured over 24 hr using the Saville reaction. As compared to controls, 5, 50, and 500 microM homocysteine produced a dose-dependent increase in media NOx content, an effect that was primarily a consequence of increased S-nitrosothiol production. iNOS enzyme activity and iNOS protein levels were increased significantly in the homocysteine-treated cells as compared with controls. Northern analysis showed that homocysteine treatment increased steady-state Nos2 mRNA levels by 61% at 6 hr as compared with controls, an effect that was not caused by changes in message stability. By electrophoretic mobility shift assay, homocysteine activated NF-kappa B and also potentiated cytokine activation of NF-kappa B. These data demonstrate that exposure of vascular smooth-muscle cells to pathophysiologically relevant concentrations of homocysteine prior to cytokine stimulation leads both to an increase in NO production and to an NF-kappa B-mediated increase in Nos2 transcription. Upregulation of Nos2 may contribute to the inflammatory response that characterizes early atherogenesis and may, in part, account for the adverse vascular effects of hyperhomocysteinemia.
血浆同型半胱氨酸水平升高是动脉粥样硬化血栓形成的一个独立危险因素。虽然同型半胱氨酸的内皮细胞毒性归因于与硫醇基团反应性相关的氧化应激,但同型半胱氨酸对血管平滑肌细胞的氧化作用尚未得到研究。最近的证据表明,血管平滑肌细胞中诱导型一氧化氮合酶(iNOS)或Nos2基因产物的表达可能部分通过增加局部氧化应激促进动脉粥样硬化。因此,我们假设同型半胱氨酸通过影响细胞因子诱导的血管平滑肌细胞一氧化氮(NO)生成来促进动脉粥样硬化。将汇合的大鼠主动脉平滑肌细胞暴露于一系列浓度的同型半胱氨酸中4小时,然后用γ干扰素、白细胞介素-1β和脂多糖处理以诱导iNOS。使用萨维尔反应在24小时内测量培养基中NOx含量(亚硝酸盐加S-亚硝基硫醇)。与对照组相比,5、50和500微摩尔同型半胱氨酸使培养基中NOx含量呈剂量依赖性增加,这种作用主要是S-亚硝基硫醇生成增加的结果。与对照组相比,同型半胱氨酸处理的细胞中iNOS酶活性和iNOS蛋白水平显著增加。Northern分析表明,与对照组相比,同型半胱氨酸处理在6小时时使稳态Nos2 mRNA水平增加61%,这种作用不是由信息稳定性变化引起的。通过电泳迁移率变动分析,同型半胱氨酸激活NF-κB并增强细胞因子对NF-κB的激活。这些数据表明,在细胞因子刺激之前,将血管平滑肌细胞暴露于病理生理相关浓度的同型半胱氨酸会导致NO生成增加以及NF-κB介导的Nos2转录增加。Nos2的上调可能有助于早期动脉粥样硬化特征性的炎症反应,并且可能部分解释高同型半胱氨酸血症的不良血管效应。